Filing Details

Accession Number:
0001264124-12-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-02 19:45:17
Reporting Period:
2012-03-01
Filing Date:
2012-03-02
Accepted Time:
2012-03-02 19:45:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881464 Amylin Pharmaceuticals Inc AMLN Pharmaceutical Preparations (2834) 330266089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236397 Daniel Bradbury 9360 Towne Centre Dr
San Diego CA 92121
President & Chief Executive Of No Yes No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-03-01 1,539 $17.11 62,912 No 4 S Direct
Common Stock Disposition 2012-03-01 4,167 $0.00 58,745 No 4 D Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 D Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Phantom Stock-Deferred Compensation Acquisiton 2012-03-01 4,167 $0.00 4,167 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
137,917 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 46,545 Indirect By GRAT
Common Stock 13,456 Indirect Indirect-401k
Common Stock 6,445 Indirect by ESOP
Common Stock 33,283 Indirect by Trust
Common Stock 23,923 Indirect by Trust-1
Footnotes
  1. Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of restricted stock units.
  2. Includes 2,273 shares recently acquired under the Company's Employee Stock Purchase Plan.
  3. These shares were previously reported as indirectly beneficially owned by The Bradbury Family Trust but were contributed to a grantor retained annuity trust on July 27, 2010.
  4. These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
  5. Shares held by the Bradbury Gift Trust, of which the reporting person's minor children are beneficiaries.
  6. Represents shares of phantom stock acquired upon vesting of restricted stock units. The reporting person deferred receipt of common shares issuable upon such vesting and instead received shares of phantom stock pursuant to Amylin's Deferred Compensation Plan.
  7. Shares of phantom stock are generally distributed to the reporting person in the form of Amylin common stock following termination of employment in accordance with the reporting person's deferral elections.